Anthony T. Cheung, PhD
Co-Founder and Chief Technology Officer
Anthony is a co-founder of enGene and has served in various capacities since enGene’s inception, including as President and Chief Executive Officer. He is currently Chief Technology Officer, overseeing the development and application of enGene’s novel and proprietary Dually Derivatized Oligochitosan (DDX) platform. He has co-authored numerous book chapters, review articles and peer-reviewed journals, and is a named inventor on numerous patents in the areas of gene therapy and polymer chemistry. Anthony holds a B.Sc. from University of British Columbia and a Ph.D. in Physiology from the Tulane University School of Medicine.